Glenmark Pharmaceuticals (GLENMARK.NSE) Q2 2025 Earnings

May 23Confirmed
Q3 2024
Q4 2024
Q1 2025
Q2 2025
10.05
11.64
13.23
14.82

Details

Expected EPS
12.04076014482
Actual EPS
10.050551856419998
Surprise EPS
-1.99
Surprise Percent
-16.53%

Description

⁨Glenmark Pharmaceuticals⁩ (⁦GLENMARK.NSE⁩) has reported earnings of ⁦10.050551856419998⁩ per share for ⁦Q2 2025⁩.

0 Comments

Share your thoughts